Skip to main content
SpringerLink
Log in

Non-Vasculitic Cutaneous Involvement

  • Chapter
  • First Online:
Book cover Sjögren’s Syndrome

  • 1215 Accesses

Abstract

As with other clinically and genetically heterogeneous, multisystem autoimmune disorders, cutaneous abnormalities are frequently encountered in Sjogren’s syndrome (SjS). Thus, it is important to have a rational framework for identifying and treating skin changes that can be encountered in SjS patients and to understand the relationships of key skin changes to the SjS systemic disease process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Flint SR, Watson R, Provost TT. Mucocutaneous manifestatons of Sjogren syndrome. In: Cutaneous manifestations of rheumatic diseases. 2 ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 135–52.

    Google Scholar 

  2. Soy M, Piskin S. Cutaneous findings in patients with primary Sjögren’s syndrome. Clin Rheumatol. 2007;26:1350–2.

    Article  PubMed  Google Scholar 

  3. Roguedas AM, Misery L, Sassolas B, Le MG, Pennec YL, Youinou P. Cutaneous manifestations of primary Sjögren’s syndrome are underestimated. Clin Exp Rheumatol. 2004;22:632–6.

    PubMed  CAS  Google Scholar 

  4. Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De PO, et al. Sjögren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol. 2004;22:55–62.

    PubMed  CAS  Google Scholar 

  5. Connolly MK. Sjogern’s syndrome. Semin Cutan Med Surg. 2001;20:46–52.

    Article  PubMed  CAS  Google Scholar 

  6. Fox RI, Liu AY. Sjögren’s syndrome in dermatology. Clin Dermatol. 2006;24:393–413.

    Article  PubMed  Google Scholar 

  7. Provost TT, Watson R. Cutaneous manifestations of Sjögren’s syndrome. Rheum Dis Clin North Am. 1992;18:609–16.

    PubMed  CAS  Google Scholar 

  8. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore). 1992 Nov;71(6):386-401; discussion 401-3. PubMed PMID: 1435231

    Google Scholar 

  9. Hart LE, Caspi D, Hull RG, Begant A, Beacham J, Hughes GR. Sweat gland function in Sjögren’s syndrome. Ann Rheum Dis. 1986;45:350–1.

    Article  PubMed  CAS  Google Scholar 

  10. Kovács L, Török T, Bari F, Kéri Z, Kovács A, Makula E, et al. Impaired microvascular response to cholinergic stimuli in primary Sjögren’s syndrome. Ann Rheum Dis. 2000;59:48–53.

    Article  PubMed  Google Scholar 

  11. Mandl T, Bornmyr SV, Castenfors J, Jacobsson LT, Manthorpe R, Wollmer P. Sympathetic dysfunction in patients with primary Sjögren’s syndrome. J Rheumatol. 2001;28:296–301.

    PubMed  CAS  Google Scholar 

  12. Bernacchi E, Bianchi B, Amato L, Giorgini S, Fabbri P, Tavoni A, et al. Xerosis in primary Sjögren syndrome: immunohistochemical and functional investigations. J Dermatol Sci. 2005;39:53–5.

    Article  PubMed  CAS  Google Scholar 

  13. Katayama I, Koyano T, Nishioka K. Prevalence of eyelid dermatitis in primary Sjögren’s ­syndrome. Int J Dermatol. 1994;33:421–4.

    Article  PubMed  CAS  Google Scholar 

  14. Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10:365–81.

    Article  PubMed  Google Scholar 

  15. Katayama I, Kotobuki Y, Kiyohara E, Murota H. Annular erythema associated with Sjögren’s syndrome: review of the literature on the management and clinical analysis of skin lesions. Mod Rheumatol. 2010;20:123–9.

    Article  PubMed  Google Scholar 

  16. Lundström IM, Lindström FD. Subjective and clinical oral symptoms in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 1995;13:725–31.

    PubMed  Google Scholar 

  17. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren’s syndrome. J Otolaryngol. 1997;26:300–5.

    PubMed  CAS  Google Scholar 

  18. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcón-Segovia D, Kraus A. Oral candidiasis and Sjögren’s syndrome. J Rheumatol. 1998;25:911–5.

    PubMed  CAS  Google Scholar 

  19. Yamamoto T, Yokoyama A, Yamamoto Y, Mamada A. Erythema nodosum associated with Sjögren’s syndrome. Br J Rheumatol. 1997;36:707–8.

    Article  PubMed  CAS  Google Scholar 

  20. McGovern TW, Erickson AR, Fitzpatrick JE. Sjögren’s syndrome plasma cell panniculitis and hidradenitis. J Cutan Pathol. 1996;23:170–4.

    Article  PubMed  CAS  Google Scholar 

  21. Chandrupatla C, Xia L, Stratman EJ. Granulomatous panniculitis associated with Sjögren syndrome. Arch Dermatol. 2008;144:815–6.

    Article  PubMed  Google Scholar 

  22. Tait CP, Yu LL, Rohr J. Sjögren’s syndrome and granulomatous panniculitis. Australas J Dermatol. 2000;41:187–9.

    Article  PubMed  CAS  Google Scholar 

  23. Massone C, Kodama K, Salmhofer W, Abe R, Shimizu H, Parodi A, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32:396–404.

    Article  PubMed  Google Scholar 

  24. Hamadah IR, Banka N. Autosomal recessive plasma cell panniculitis with morphea-like clinical manifestation. J Am Acad Dermatol. 2006;54(5 Suppl):S189–91.

    Article  PubMed  Google Scholar 

  25. Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al. Sjögren’s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58:1992–9.

    Article  PubMed  Google Scholar 

  26. Yoneyama K, Tochigi N, Oikawa A, Shinkai H, Utani A. Primary localized cutaneous nodular amyloidosis in a patient with Sjögren’s syndrome: a review of the literature. J Dermatol. 2005;32(2):120–3.

    PubMed  Google Scholar 

  27. Schwendiman MN, Beachkofsky TM, Wisco OJ, Owens NM, Hodson DS. Primary cutaneous nodular amyloidosis: case report and review of the literature. Cutis. 2009;84:87–92.

    PubMed  Google Scholar 

  28. Konishi A, Fukuoka M, Nishimura Y. Primary localized cutaneous amyloidosis with unusual clinical features in a patient with Sjögren’s syndrome. J Dermatol. 2007;34:394–6.

    Article  PubMed  Google Scholar 

  29. Srivastava M. Primary cutaneous nodular amyloidosis in a patient with Sjögren’s syndrome. J Drugs Dermatol. 2006;5:279–80.

    PubMed  Google Scholar 

  30. Kitajima Y, Seno J, Aoki S, Tada S, Yaoita H. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils. Arch Dermatol. 1986;122:1425–30.

    Article  PubMed  CAS  Google Scholar 

  31. Inazumi T, Hakuno M, Yamada H, Tanaka M, Naka W, Tajima S, et al. Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren’s syndrome. Dermatology. 1994;189:125–8.

    Article  PubMed  CAS  Google Scholar 

  32. Aoki A, Ono S, Ueda A, Hagiwara E, Takashi T, Ideguchi H, et al. Two cases of limited cutaneous nodular amyloidosis with primary Sjögren’s syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 2002;25:205–11.

    Article  PubMed  Google Scholar 

  33. Richey TK, Bennion SD. Etiologies of the sicca syndrome: primary systemic amyloidosis and others. Int J Dermatol. 1996;35(8):553–7.

    Article  PubMed  CAS  Google Scholar 

  34. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888–92.

    PubMed  CAS  Google Scholar 

  35. Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029–38.

    Article  PubMed  Google Scholar 

  36. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–44.

    Article  PubMed  Google Scholar 

  37. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum. 2002;46:741–7.

    Article  PubMed  Google Scholar 

  38. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum. 2000;29:296–304.

    Article  PubMed  CAS  Google Scholar 

  39. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren’s Syndrome. Arthritis Rheum. 1999;42:1765–72.

    Article  PubMed  CAS  Google Scholar 

  40. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore). 2009;88:284–93.

    Article  Google Scholar 

  41. Ramos-Casals M, Brito-Zerón P, Perez-DE-Lis M, Diaz-Lagares C, Bove A, Soto MJ, et al. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren’s syndrome. J Rheumatol. 2010;37:585–90.

    Article  PubMed  Google Scholar 

  42. Renic A, Nousari HC. Other rheumatologic diseases. In: Bolognia J, Jorizzo J, Rapini R, ­editors. Dermatology. Elsevier; Burlington, Massachusetts, USA 2003. p 636–8.

    Google Scholar 

  43. Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sjögren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766–75.

    PubMed  CAS  Google Scholar 

  44. Quartuccio L, Fabris M, Salvin S, Maset M, De Marchi G, De Vita S. Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. Int J Rheumatol. 2009;2009:424935.

    PubMed  Google Scholar 

  45. Kristinsson SY, Koshiol J, Björkholm M, Goldin LR, McMaster ML, Turesson I, et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst. 2010;102(8):557–67.

    Article  PubMed  CAS  Google Scholar 

  46. Yokota K, Akiyama Y, Adachi D, Shindo Y, Yoshida Y, Miyoshi F, et al. Subcutaneous panniculitis-like T-cell lymphoma accompanied by Sjögren’s syndrome. Scand J Rheumatol. 2009;38:494–5.

    Article  PubMed  CAS  Google Scholar 

  47. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979;115:1409–15.

    Article  PubMed  CAS  Google Scholar 

  48. Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev. 2005;4:253–63.

    Article  PubMed  CAS  Google Scholar 

  49. Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stastny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med. 1982;97:644–71.

    Google Scholar 

  50. Black DR, Hornung CA, Schneider PD, Callen JP. Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol. 2002;138:1175–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

There was no extramural support for this project. Dr. Sontheimer’s effort on this project were facilitated by internal support from the University of Utah Department of Dermatology in return for his work in strengthening the departmental academic mission. We express our appreciation to the following individuals who generously provided clinical images to illustrate this chapter: Jan P. Dutz, M.D. (Department of Dermatology, University of British Columbia, Canada) as well as Glen M. Bowen, M.D. and Scott R. Florell, M.D. (Department of Dermatology, University of Utah School of Medicine, USA).

Conflicts of interest None to declare.

External funding sources None.

Author information

Authors and Affiliations

  1. Private Practice of Dermatology, Coralville, IA, USA

    Hobart W. Walling

  2. Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA

    Richard D. Sontheimer

Authors
  1. Hobart W. Walling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard D. Sontheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Barcelona, Surgey, Hospital Clinic, Calle Villarroel, 170, Barcelona, 08036, Spain

    Manuel Ramos-Casals

  2. Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    John H. Stone

  3. National University of Athens, Athens, Greece

    Haralampos M. Moutsopoulos

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Walling, H.W., Sontheimer, R.D. (2011). Non-Vasculitic Cutaneous Involvement. In: Ramos-Casals, M., Stone, J., Moutsopoulos, H. (eds) Sjögren’s Syndrome. Springer, London. https://doi.org/10.1007/978-0-85729-947-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-947-5_11

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-946-8

  • Online ISBN: 978-0-85729-947-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation